TW200510363A - Use of substituted chromans or thiocromans for the treatment of FGD - Google Patents

Use of substituted chromans or thiocromans for the treatment of FGD

Info

Publication number
TW200510363A
TW200510363A TW093116446A TW93116446A TW200510363A TW 200510363 A TW200510363 A TW 200510363A TW 093116446 A TW093116446 A TW 093116446A TW 93116446 A TW93116446 A TW 93116446A TW 200510363 A TW200510363 A TW 200510363A
Authority
TW
Taiwan
Prior art keywords
thiocromans
treatment
fgd
substituted
substituted chromans
Prior art date
Application number
TW093116446A
Other languages
Chinese (zh)
Inventor
Seth-Olov Thorberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TW200510363A publication Critical patent/TW200510363A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to the use of substituted 3-amino chromans or thiocromans as well as enantiomers and salts thereof for the treatment of functional gastrointestinal disorders, such as functional dyspepsia.
TW093116446A 2003-06-19 2004-06-08 Use of substituted chromans or thiocromans for the treatment of FGD TW200510363A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301796A SE0301796D0 (en) 2003-06-19 2003-06-19 New use II

Publications (1)

Publication Number Publication Date
TW200510363A true TW200510363A (en) 2005-03-16

Family

ID=27607361

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093116446A TW200510363A (en) 2003-06-19 2004-06-08 Use of substituted chromans or thiocromans for the treatment of FGD

Country Status (4)

Country Link
AR (1) AR044716A1 (en)
SE (1) SE0301796D0 (en)
TW (1) TW200510363A (en)
WO (1) WO2004110430A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904361D0 (en) * 1989-12-22 1989-12-22 Astra Ab NEW CHROMAN AND THIOCHROMAN DERIVATIVES
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
EP0498590B1 (en) * 1991-02-08 1997-04-09 Eli Lilly And Company Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes
US5434174A (en) * 1992-07-17 1995-07-18 Eli Lilly And Company Isoxazole derivatives for the treatment of irritable bowel syndrome
SE510305C2 (en) * 1997-05-30 1999-05-10 Astra Ab Fresh salt

Also Published As

Publication number Publication date
WO2004110430A1 (en) 2004-12-23
AR044716A1 (en) 2005-09-21
SE0301796D0 (en) 2003-06-19

Similar Documents

Publication Publication Date Title
SE0203713D0 (en) Novel compounds
TW200510301A (en) Novel compounds
TW200510303A (en) Novel compounds
TW200407305A (en) Novel compounds
TW200612892A (en) Novel compounds
WO2007079214A3 (en) Prokineticin 2 receptor antagonists
NO20064325L (en) Heteroberlaminopyrazole derivatives useful for the treatment of diabetes
SE0303180D0 (en) Novel compounds
CY1110209T1 (en) Substituted Benzo (D) isoxazol-3-yl-amine compounds as analgesics
MX2007011847A (en) Pyrimidindione derivatives as prokineticin 2 receptor antagonists.
HK1080467A1 (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
NO20055741L (en) New chemical compounds
CY1108808T1 (en) MOTORCYCLE UNITS
MXPA05004621A (en) Anilinopyrazole derivatives useful for the treatment of diabetes.
NO20055563L (en) Means for the treatment of lower abdominal disorders
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
DE602006003094D1 (en) 4-PHENYL-5-OXO-1,4,5,6,7,8-HEXAHYDROCHINOLINE DERIVATIVES FOR THE TREATMENT OF BARRENESS
WO2006058720A3 (en) Novel compounds for the treatment of neurological disorders
WO2005112923A3 (en) 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
PT1606288E (en) Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
WO2006067599A3 (en) Stable oral benzimidazole compositions and process of preparation thereof
EA200400438A1 (en) THE USE OF IRBESARTAN FOR THE PRODUCTION OF DRUGS WHICH ARE SUITABLE FOR THE PREVENTION OR TREATMENT OF PULMONARY HYPERTENSION
TW200738689A (en) Salts and polymorphs of a VEGF-R inhibitor
MXPA04004090A (en) Substituted 1h-quinolin-2-one compounds.
TW200510363A (en) Use of substituted chromans or thiocromans for the treatment of FGD